World Health Organization Raises Warning Over Critical Scarcity of Obesity Medications
Fewer than 10% of patients that would benefit from obesity jabs such as Wegovy can access them, caution the global health agency as it releases its inaugural guidance on the drugs.
With more than one billion individuals worldwide currently classified as obese, it is calling for broader and more equitable availability to this class of drugs.
Based on forecasts, in excess of 2,000,000,000 will be living with obesity by 2030 if no action is taken.
"Our latest guidance acknowledges that obesity is a lifelong illness that can be addressed with comprehensive and ongoing treatment," remarked WHO director-general Tedros Adhanom Ghebreyesus.
High costs, insufficient output, and supply-chain constraints are significant hurdles to universal availability to the injections that can aid individuals in losing considerable body mass, says the organization.
Skinny Jab Supply Crisis
Even under the present best projected outlook, the supply of GLP-1 therapies might only reach about 100 million people – fewer than 10% of the global need, according to the WHO.
The guideline urges governments and firms to increase access, via approaches including licensing agreements.
A patent on a key compound – the main component of a leading brand – is scheduled to end in a number of nations in 2026.
How Weight-Loss Jabs Operate
The injections replicate a biological compound to reduce digestion speed, suppress the appetite and enhance the sense of being full so people reduce food intake.
People usually begin shedding pounds after several weeks of starting on the regular doses.
Evidence points to people may regain a significant portion after a year of stopping the drug, because their usual appetite come back.
To be overweight or obese elevates your chance for experiencing health problems, like diabetes, heart disease, stroke, and certain cancers.
Obesity impacts people in countries worldwide and was linked to 3.7 million deaths worldwide in 2024, according to the health agency.
